Senior insider sale
Chief Strategy Officer at OCULAR THERAPEUTIX, INC — senior position signals high conviction
$45.3K
3.76K shares
What this filing means
NAYAK SANJAY plans to sell 3.76K shares of OCULAR THERAPEUTIX, INC valued at approximately $45.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 11/24/2025ACC: 0001950047-25-009290
Officer· Chief Strategy Officer
Since Feb 2026
3.76K
Shares to sell
$45.3K
Approx. market value
1.88K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted stock vesting under a registered plan
Compensation
11/22/2025
1.88KTotal acquired1.88K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
11/22/2025 | Restricted stock vesting under a registered plan Compensation | 1.88K | — |
| Total | 1.88K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
1.89K
Market value
$22.7K
8/25/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
1.88K
Market value
$22.6K
11/24/2025
Total
Units
3.76K
Value
$45.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
8/25/2025 | 1.89K | $22.7K | — | Completed |
| Planned — Approximate Date | ||||
11/24/2025 | 1.88K | $22.6K | NASDAQ | Planned |
| Total | 3.76K | $45.3K | ||